(RYTM) Rhythm Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Rhythm Pharmaceuticals | (RYTM) share price targets
Complete technical analysis of Rhythm Pharmaceuticals (RYTM) by charts plus indicators, forecast predictions and share price targets for Rhythm Pharmaceuticals (RYTM)
Rhythm Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-28 View latest technical analysis
10 day averaged volume of Rhythm Pharmaceuticals is 636920
| Date | Daily Closing Price | Open | High | Low | Volume |
| 28 Fri Jun 2024 | 41.06 | 40.37 | 41.14 | 39.46 | 1.719 times |
| 27 Thu Jun 2024 | 40.13 | 40.01 | 40.64 | 39.47 | 0.56 times |
| 26 Wed Jun 2024 | 39.87 | 42.58 | 42.58 | 39.74 | 0.752 times |
| 25 Tue Jun 2024 | 42.75 | 42.42 | 43.33 | 41.99 | 0.63 times |
| 24 Mon Jun 2024 | 42.53 | 42.00 | 43.39 | 41.56 | 0.84 times |
| 21 Fri Jun 2024 | 41.87 | 40.72 | 42.20 | 40.54 | 3.486 times |
| 20 Thu Jun 2024 | 40.68 | 41.12 | 41.12 | 40.06 | 0.646 times |
| 18 Tue Jun 2024 | 41.39 | 41.35 | 41.48 | 40.09 | 0.559 times |
| 18 Tue Jun 2024 | 41.39 | 41.35 | 41.48 | 40.09 | 0.559 times |
| 17 Mon Jun 2024 | 41.16 | 42.36 | 42.38 | 40.48 | 0.794 times |
My analysis of stock is bullish for shortterm, and stock might move up till 42.5 or till 44.3. Use a stoploss of 40.97 and if this stock hits its stoploss, then it can fall down till 39.47
Share price targets for Rhythm Pharmaceuticals (RYTM)
| Target Type | Value |
| Downside Target | 35.17 |
| Downside Target | 36.27 |
| Downside Target | 37.66 |
| Downside Target | 38.90 |
| Upside Target | 42.20 |
| Upside Target | 43.39 |
| Upside Target | 43.68 |
| Upside Target | 44.37 |
| Upside Target | 45.49 |
| Upside Target | 45.92 |
| Upside Target | 52.57 |
Intraday share price targets for Rhythm Pharmaceuticals (RYTM)
| Target Type | Value |
| Downside Intraday Target | 39.22 |
| Downside Intraday Target | 37.37 |
| Upside Intraday Target | 43.15 |
| Upside Intraday Target | 45.23 |
| Upside Intraday Target | 41.3 |
Weekly technical analysis of Rhythm Pharmaceuticals (RYTM)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 28 Fri Jun 2024 | 41.06 | 42.00 | 43.39 | 39.46 | 0.959 times |
| 21 Fri Jun 2024 | 41.87 | 41.35 | 42.20 | 40.06 | 3.467 times |
| 18 Tue Jun 2024 | 41.39 | 42.36 | 42.38 | 40.09 | 0.291 times |
| 14 Fri Jun 2024 | 42.77 | 39.31 | 45.92 | 38.90 | 1.081 times |
| 07 Fri Jun 2024 | 39.97 | 36.40 | 40.50 | 36.27 | 1.391 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Rhythm Pharmaceuticals (RYTM)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 28 Fri Jun 2024 | 41.06 | 36.40 | 45.92 | 36.27 | 1.007 times |
| 31 Fri May 2024 | 35.68 | 39.77 | 44.37 | 35.17 | 1.153 times |
| 30 Tue Apr 2024 | 39.76 | 42.30 | 43.68 | 36.92 | 0.887 times |
| 28 Thu Mar 2024 | 43.33 | 42.67 | 45.49 | 37.66 | 0.956 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Rhythm Pharmaceuticals (RYTM)
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Rhythm Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Rhythm Pharmaceuticals in short term but the sell signal is initial and weak.
Rhythm Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Rhythm Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Rhythm Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 41.43 and Rhythm Pharmaceuticals (RYTM) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Rhythm Pharmaceuticals (RYTM) stock. Volume based technical analysis of Rhythm Pharmaceuticals (RYTM) stock is negative.
Rhythm Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Rhythm Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Rhythm Pharmaceuticals in short term but the sell signal is initial and weak.
Rhythm Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Rhythm Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Rhythm Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 41.43 and Rhythm Pharmaceuticals (RYTM) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Rhythm Pharmaceuticals (RYTM) stock. Volume based technical analysis of Rhythm Pharmaceuticals (RYTM) stock is negative.
Rhythm Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.